Despite it being under price control, Human Mixtard alone is a Rs 800 crore brand ... filled disposable pen and cartridges (Penfill and FlexPen). TOI accessed documents that said the company ...

which are marketed primarily in the format of pre-filled disposable pen and cartridges (Penfill and FlexPen).’ Post this media report Novo Nordisk has issued an official statement stating, “We wish to ...

The TOI report noted that Human Mixtard, a Rs 800 crore brand despite ... such as pre-filled pens and cartridges (Penfill and FlexPen). Read report: Novo Nordisk to phase out country’s largest ...

But Novo Nordisk's biphasic analogue insulin is prescribed 50% more often than Mixtard 30, it points out, possibly because it comes in a particularly convenient pen format (FlexPen). "It is ...

Human Mixtard alone is a Rs 800 crore brand for ... the format of pre-filled disposable pen and cartridges (Penfill and FlexPen). The company recently informed its marketing partner, Abbott ...

A warning has been issued to those patients that are still taking the insulin Mixtard 30 to treat their diabetes to ensure they have moved to an alternative by the end of the year. With manufacturer ...

A small number of batches of the insulin medication NovoMix 30 FlexPen and Penfill (Novo Nordisk) are to be recalled in the European Union, and the European Medicines Agency (EMA) is recommending ...

Princeton, NJ (September 27, 2004) – In type 2 diabetes patients, use of NovoLog® Mix 70/30 FlexPen® (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin ...

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...

A popular diabetes drug used by thousands will no longer be available in the UK but doctors are concerned by the effects on both their patients and the added financial burden on the NHS.

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...